Brief: Exscientia Presents Novel Immuno-Oncology Biomarker For EXS-21546 At The ESMO I-O Annual Congress
06/12/2022 12:39
Dec 6 (Reuters) - Exscientia PLC EXAI.O :
* EXSCIENTIA PRESENTS NOVEL IMMUNO-ONCOLOGY BIOMARKER FOR
EXS-21546 AT THE ESMO I-O ANNUAL CONGRESS
Source text for Eikon: ID:nBw1Dbj5ya
Further company coverage: EXAI.O
Recent news on Exscientia
See all newsExscientia PLC expected to post a loss of 9 cents a share - Earnings Preview
Brief: Exscientia Achieves Milestones For Two Programmes In Sanofi Collaboration
Exscientia PLC reports results for the quarter ended in June - Earnings Summary
Deals of the day-Mergers and acquisitions
Biotech firm Recursion to buy smaller peer Exscientia for $688 million